BioCentury | Oct 6, 2020
Deals
Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more
...#), nivolumab (Generic), Opdivo (Other)
sotorasib (AMG 510)
lifileucel (LN-144, contego, TILs)
omburtamab, 124I-8H9 (B7-H3), burtomab (8h9)
Eidos Therapeutics
BridgeBio Pharma
Hugo Biotech
Zhejiang...
